BD to sell surgical devices business, 3 manufacturing facilities

Becton Dickinson plans to sell its surgical devices business and three manufacturing plants as part of a divestment planned for the end of 2023. 

Advertisement

Steris, an Ireland-based medical devices company, will buy Becton Dickinson’s surgical products business for $540 million, which includes manufacturing sites in St. Louis, Cleveland and Tuttlingen, Germany, according to a June 20 news release.

“Divesting the platform advances [… the company’s] 2025 strategy and is an important step in simplifying BD’s product portfolio and manufacturing network,” the release said.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

  • Aurora, Colo.-based UCHealth Vice President of Supply Chain Richard Bagley has retired after more than four years with the health…

  • The FDA has flagged eight medical device recalls, corrections and early alerts affecting convenience kits, vascular access devices, IV administration…

Advertisement

Comments are closed.